表紙
市場調查報告書

男性不孕症診斷、治療的全球市場的調查、分析

Global Male Infertility Diagnosis and Treatment Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 505706
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
男性不孕症診斷、治療的全球市場的調查、分析 Global Male Infertility Diagnosis and Treatment Market 2019-2025
出版日期: 2019年12月20日內容資訊: 英文
簡介

本報告提供全球男性不孕症診斷、治療的市場相關分析,產品概要和市場基本結構,來自外部的宏觀、微觀的影響,主要的促進、阻礙因素,各診斷/治療手段、各地區的市場趨勢預測 (過去2年、今後6年份),最新的市場競爭情形,主要企業簡介、最新趨勢等調查。

第1章 分析概要

第2章 市場概要與考察

  • 定義
  • 分析師的見解與目前市場趨勢
  • 全球各國的法規情形 (美國,EU各國,中國,印度等)

第3章 市場決策要素

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會

第4章 市場區隔

  • 全球男性不孕症診斷的市場
    • 精子分析
    • 遺傳基因檢驗
    • 精巢切片檢查
    • 荷爾蒙水準檢驗
    • 其他
  • 全球男性不孕症治療的市場
    • 藥物治療
    • 手術
    • 輔助生殖技術醫療 (ART)
    • 其他

第5章 競爭環境

  • 主要策略分析
  • 主要企業分析

第6章 地區分析

  • 北美 (美國,加拿大等)
  • 歐洲 (英國,法國,德國,義大利,西班牙等)
  • 亞太地區 (印度,中國,日本)
  • 其他國家 (RoW)

第7章 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: OMR2020054

Male Infertility Diagnosis and Treatment Market Size, Share & Trends Analysis Report, By Diagnostic Tests (Semen Analysis, Urinalysis, Genetic Testing, Testicular Biopsy, Hormonal Tests and Others) By Treatment (Drugs, ART Therapy and Surgery) and Forecast, 2019-2025

The global male infertility diagnosis and treatment market is anticipated to witness modest growth during the forecast period. The major factors augmenting the growth of the market include significant growth in infertility rates, lifestyle associated risk factors and advances in male infertility treatment. Alcohol consumption is estimated to be one of the unhealthy lifestyle habits that may contribute to a rise in male infertility cases. According to World Health Organization (WHO), Alcohol is consumed by more than half of the population in the Americas, Europe and the Western Pacific. Total alcohol per capita consumption in the global population over 15 years of age rose from 5.5 liters of pure alcohol in 2005 and reached at the level of 6.4 liters in 2016.

The highest levels of per capita alcohol consumption are observed in countries of the WHO European region. Heavy alcohol consumption among men may cause infertility as it can decrease the production of normally formed sperm by interfering with the functioning of the male reproductive system. It can disrupt testosterone levels that produce both sperm and testosterone. Both long- and short-term heavy alcohol consumption has been shown to decrease testosterone level which may lead to the rise in infertility rates. However, high-cost of infertility treatment is the major restraining factor for the market growth.

Based on the geography, the market is further analyzed on the basis of four major regions including North America, Europe, Asia-Pacific and RoW. North America is anticipated to hold the largest share in the market owing to significant awareness regarding infertility in the region. Furthermore, the rising incidences of infertility are also one of the major factors encouraging the growth of the market in the region. For instance, as per the US Department of Health and Human Services (HHS), out of 100 couples in the US, 12 to 13 have trouble conceiving. Of which, nearly one-third of infertility cases reported due to fertility problems in men in the US. Asia Pacific is anticipated to witness optimistic growth in the market owing to the rising awareness among the population for infertility treatment and significant growth in infertility centers in the region

The major players in the market include Merck KGaA, Halotech DNA SL, PerkinElmer, Inc., Vitrolife AB and Medical Electronic Systems. In order to survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market.

Research Methodology

The market study of the global male infertility diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for providers of in-vitro diagnostics tools, infertility diagnostic tests and treatment alternatives for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Male Infertility Diagnosis and Treatment Market Research and Analysis, By Diagnostic Tests
  • Global Male Infertility Diagnosis and Treatment Market Research and Analysis, By Treatment

The Report covers:

  • Comprehensive research methodology of the global male infertility diagnosis and treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global male infertility diagnosis and treatment market.
  • Insights about market determinants which are stimulating the global male infertility diagnosis and treatment market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Merck KGaA
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Halotech DNA SL
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. PerkinElmer, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Vitrolife AB
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Medical Electronic Systems
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Male Infertility Diagnosis and Treatment Market by Diagnostic Tests
    • 5.1.1. Semen Analysis
    • 5.1.2. Urinalysis
    • 5.1.3. Genetic Testing
    • 5.1.4. Testicular Biopsy
    • 5.1.5. Hormonal Tests
    • 5.1.6. Others (Anti-sperm Antibodies Test and Ultrasound)
  • 5.2. Global Male Infertility Diagnosis and Treatment Market by Treatment
      • 5.2.1.1. Drugs
      • 5.2.1.2. ART Therapy
      • 5.2.1.3. Surgery

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. US
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Androvia LifeSciences
  • 7.2. ASKA Pharmaceutical Co., Ltd.
  • 7.3. Aytu BioScience, Inc.
  • 7.4. Bayer AG
  • 7.5. Bristol-Myers Squibb Co.
  • 7.6. Cadila Pharmaceuticals Ltd.
  • 7.7. Centogene AG
  • 7.8. Cook Medical, Inc.
  • 7.9. CooperSurgical Fertility & Genomic Solutions
  • 7.10. Cordex Pharma, Inc.
  • 7.11. Eli Lilly and Co.
  • 7.12. FUJIFILM Irvine Scientific
  • 7.13. Halotech DNA SL
  • 7.14. Intas pharmaceuticals Ltd.
  • 7.15. Medical Electronic Systems
  • 7.16. Merck KGaA
  • 7.17. Microm UK Ltd.
  • 7.18. myLAB
  • 7.19. Pantarhei Bioscience B.V.
  • 7.20. PerkinElmer, Inc.
  • 7.21. Pfizer, Inc.
  • 7.22. Sanofi S.A.
  • 7.23. SCSA Diagnostics, Inc.
  • 7.24. Vitrolife AB

List of Tables

1. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2018-2025 ($ MILLION)

2. GLOBAL SEMEN ANALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL URINALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL GENETIC TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL TESTICULAR BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

6. GLOBAL HORMONAL TESTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL OTHER MALE INFERTILITY DIAGNOSTIC TESTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

9. GLOBAL DRUGS FOR MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

10. GLOBAL ART THERAPY FOR MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

11. GLOBAL SURGERY FOR MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

12. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

13. NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

14. NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2018-2025 ($ MILLION)

15. NORTH AMERICAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

16. EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

17. EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2018-2025 ($ MILLION)

18. EUROPEAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

19. ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

20. ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2018-2025 ($ MILLION)

21. ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

22. REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TESTS, 2018-2025 ($ MILLION)

23. REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)

List of Figures

1. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSTIC TESTS, 2018 VS 2025 (%)

2. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)

3. GLOBAL MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. US MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

6. UK MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

10. SPAIN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

11. ROE MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

12. INDIA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

13. CHINA MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

14. JAPAN MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD MALE INFERTILITY DIAGNOSIS AND TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)